Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

Cryptogenic strokes constitute 20 to 30% of ischemic strokes, and most cryptogenic strokes are considered to be embolic and of undetermined source. An earlier randomized trial showed that rivaroxaban is no more effective than aspirin in preventing recurrent stroke after a presumed embolic stroke fro...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hans‐Christoph Diener, Ralph L. Sacco, J. Donald Easton, Christopher B. Granger, Richard A. Bernstein, Shinichiro Uchiyama, Jörg Kreuzer, Lisa Cronin, Otto W. Witte, Claudia Grauer, Martina Brueckmann, M. A. Chernyatina, Geoffrey A. Donnan, José M. Ferro, Martin Grond, Bernd Kallmünzer, Jerzy Krupiński, Byung‐Chul Lee, Robin Lemmens, Jaime Masjuán, Miroslav Odinak, Jeffrey L. Saver, Peter D. Schellinger, Danilo Toni, Ḱazunori Toyoda
Médium: Artigo
Jazyk:angličtina
Vydáno: 2019
On-line přístup:https://doi.org/10.1056/nejmoa1813959
https://www.nejm.org/doi/pdf/10.1056/NEJMoa1813959?articleTools=true
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.1056/nejmoa1813959
https://www.nejm.org/doi/pdf/10.1056/NEJMoa1813959?articleTools=true

Podobné jednotky